Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 38Active not recruiting 12Recruiting 9Terminated 4Withdrawn 3Unknown 3Not yet recruiting 1No longer available 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Colorectal Neoplasms 39Stomach Neoplasms 20Carcinoma, Hepatocellular 20Pancreatic Neoplasms 15Colonic Neoplasms 13Esophageal Neoplasms 10Liver Neoplasms 9Rectal Neoplasms 8Esophageal Squamous Cell Carcinoma 8Cholangiocarcinoma 8Breast Neoplasms 8Barrett Esophagus 8Carcinoma, Non-Small-Cell Lung 6Neoplasms 5Postoperative Complications 4Liver Cirrhosis 4Gastrointestinal Neoplasms 4Gallbladder Neoplasms 4Diabetes Mellitus 4Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Lymphatic Metastasis 3Lung Neoplasms 3Fibrosis 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Anastomotic Leak 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Neuroblastoma × Gastrointestinal × Clear all
NCT01868490 2025-02-10

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Siriraj Hospital

Phase 1/2 Enrolling by invitation
20 enrolled
CNSGastrointestinal

Neuroblastoma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡